# Tempus AI Inc.

Type: Company (TEM)

Source: GetYourBrief — https://getyourbrief.com/entity/tempus-ai-inc-company
Canonical HTML page: https://getyourbrief.com/entity/tempus-ai-inc-company

## Recent coverage (3 stories, network-wide)

### Cathie Wood Doubles Down on AI: ARK Invest Buys $2M of Tempus AI Amid Slump
2026-03-16 00:34:29 · Sector: ai · Sentiment: Neutral · Impact: 5/10 · Sources: 3

ARK Invest CEO Cathie Wood has increased her position in Tempus AI with a $2 million purchase, signaling continued conviction in AI-driven healthcare despite a 15% year-to-date decline. This move comes as Wood's flagship ARKK fund faces renewed pressure, trailing the S&P 500 significantly over a five-year horizon.
Full story: https://getaibrief.com/story/cathie-wood-ark-invest-tempus-ai-purchase

### Cathie Wood Doubles Down on AI with $2M Tempus AI Buy Amid Market Slump
2026-03-16 00:33:20 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 3

ARK Invest CEO Cathie Wood has increased her stake in Tempus AI with a $2 million purchase, signaling continued conviction in high-growth technology despite a 15% year-to-date decline for the stock. This move comes as her flagship Ark Innovation ETF struggles to keep pace with the broader market, currently trailing the S&P 500 as Wood maintains her stance that the AI sector is far from a bubble.
Full story: https://getfinancebrief.com/story/cathie-wood-ark-tempus-ai-investment-analysis

### ARK Invest Doubles Down on Tempus AI Amid Precision Medicine Volatility
2026-03-16 00:32:42 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Cathie Wood's ARK Investment Management has purchased $2 million worth of Tempus AI shares, reinforcing its position in the precision medicine firm despite a 15% year-to-date decline. The move underscores Wood's commitment to 'coiled spring' AI and biotech assets, even as her flagship funds face significant performance headwinds compared to the broader market.
Full story: https://getbiobrief.com/story/ark-invest-tempus-ai-purchase-precision-medicine

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.